In line with our findings, a correlation between high FGF23 and defective bone microarchitecture has been shown in either adult TIO patients (9) or osteoporotic patients (25), and severe hypophosphatemia has also been shown to cause a compromised bone microarchitecture and bone strength in adult XLH patients (12). This evidence concerns the gene FGF23 and hypophosphatemia.